Both in Ophthalmic Goods
Bausch + Lomb vs RxSight
Over the past year BLCO returned +37.3% and RXST returned −44.6%; their daily moves had a correlation of 0.34.
BLCO +37.3% RXST −44.6%Growth of $1, one year, split-adjusted
| Metric | BLCO | RXST |
|---|---|---|
| Price | $20.60 | $4.99 |
| Market cap | $7.36B | $207.6M |
| Today | +2.85% | +8.71% |
| 1 month | +19.9% | +7.3% |
| 6 months | +28.8% | −26.4% |
| Year to date | +20.6% | −52.1% |
| 1 year | +35.1% | −42.5% |
| Revenue growth (YoY) | +7.3% | +0.3% |
| Gross margin | 64.7% | 76.7% |
| Net margin | 2.3% | −35.9% |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | 1.6× |
| Net cash | -$4.58B | $208.8M |
| Dividend yield | — | — |
| Volatility (60d) | 39.1% | 50.8% |
| Short % of float | 5.5% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).